WILMINGTON, MASSACHUSETTS--(Marketwire - November 04, 2008) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008 at 11:10 a.m. ET at The New York Palace Hotel in New York. Interested investors can access the live audio webcast of the presentation at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website for 14 days following the presentation.
